MBX Biosciences, Inc. — Form D

MBX Biosciences, Inc. of CARMEL, IN, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-18. The offering totals $115.2M, of which $46.7M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2022-11-18
Form: D
Accession: 0001776111-22-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $115.2M
Amount sold: $46.7M
Remaining: $68.5M
Investors: 20
Date of first sale: 2022-11-07
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-465364

Issuer

Name: MBX Biosciences, Inc.
CIK: 0001776111
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2019
Address: 11711 N. Meridian Street, Suite 300, CARMEL, IN, 46032
Phone: 317-659-0200

Officers, directors & promoters (13)

Name	Role	Location
Tiba M Aynechi	Director	Carmel, IN
James M Cornelius	Director	Carmel, IN
Richard Kent DiMarchi	Director	Carmel, IN
Carl M Gordon	Director	Carmel, IN
Peter Kent Hawryluk	Director	Carmel, IN
Patrick M Heron	Director	Carmel, IN
Edward M Mathers	Director	Carmel, IN
Ora Kent Pescovitz	Director	Carmel, IN
Richard M Bartram	Executive Officer	Carmel, IN
Richard Kent DiMarchi	Executive Officer	Carmel, IN
Peter Kent Hawryluk	Executive Officer	Carmel, IN
Timothy Kent Knickerbocker	Director	Carmel, IN
Timothy Kent Knickerbocker	Executive Officer	Carmel, IN

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2020-07-27	D	$35.8M	$25.8M
2019-05-10	D/A	$5.0M	$2.3M
2019-05-10	D	$50.0M	$23.0M

More